Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Pharmaceutical industry

Gilead hepatitis C drug sales trend flattens, shares dip

Editor's pick
Reuters
28 October 2015
Hepatitis C treatment

New Yorkers on pace to spend $1 B. on Hepatitis C cures

Editor's pick
Capital New York
27 October 2015
Hepatitis C treatment

Hepatitis C Guidance Underscores the Importance of Treating HCV Infection: Panel Recommends Direct-Acting Drugs for Nearly All Patients with Chronic Hepatitis C

Editor's pick
IDSA
27 October 2015
Hepatitis C treatment

Prevalence and Care for Hep C Varies Widely Across Continent

Editor's pick
Medscape
27 October 2015
Hepatitis C treatment

Viekira Pak, Technivie May Up Serious Liver Injury Risk: FDA

Editor's pick
Medscape
23 October 2015
New & experimental hepatitis C treatment

NICE Recommends Daklinza (daclatasvir) for Treatment of Certain Patients with Chronic Hepatitis C Genotypes 1, 3 and 4

Editor's pick
Bristol-Myers Squibb press release
16 October 2015
Hepatitis C treatment

NYU Research: Development of Severe Liver Damage in Mid/Late-adulthood among People Who Inject Drugs with Chronic HCV

Editor's pick
New York University press release
12 October 2015
New & experimental hepatitis C treatment

U.S. FDA Grants Priority Review For Daklinza (daclatasvir) sNDAs

Editor's pick
Bristol-Myers Squibb
7 October 2015
Hepatitis C treatment

Rising death rates and burden of liver disease requires urgent hepatitis C treatment in people who inject or have injected drugs

Editor's pick
Kirby Institute press release
7 October 2015
Hepatitis C treatment

NYU researchers find development of serious liver damage in mid- to late-adulthood among people who inject drugs with untreated chronic hepatitis C infection

Editor's pick
NYU press release
6 October 2015
Hepatitis C treatment

Treating 5 percent of hepatitis C patients with new drugs would reduce cost and infections, study shows

Editor's pick
USC News
6 October 2015
Access to healthcare

FixHepC, the buyers club for hepatitis C drug, inundated with inquiries

Editor's pick
Sydney Morning Herald
2 October 2015
Access to healthcare

Hepatitis C drug buyers club aims to set up new source of support

Editor's pick
Sydney Morning Herald
28 September 2015
New & experimental hepatitis C treatment

Gilead Announces SVR12 Rates from Four Phase 3 Studies Evaluating a Once-Daily, Fixed-Dose Combination of Sofosbuvir (SOF) and Velpatasvir (VEL) (GS-5816) for the Treatment of All Six Hepatitis C Genotypes

Editor's pick
Gilead press release
21 September 2015
People who inject drugs

What We Talk About When We Talk About Hepatitis C

Editor's pick
Huffington Post
18 September 2015
New & experimental hepatitis C treatment

Ongoing Real World Study Reports High Sustained Viral Response Rates with VIEKIRAX® + EXVIERA® in Genotype 1 Hepatitis C Patients

Editor's pick
AbbVie press release
14 September 2015
Hepatitis C treatment

People living with hepatitis C in Canada want more information about living well and getting treatment

Editor's pick
CATIE
2 September 2015
Hepatitis C treatment

One in four hepatitis C patients denied initial approval for drug treatment

Editor's pick
Yale News
28 August 2015
Hepatitis C treatment

White House Is Pressed to Help Widen Access to Hepatitis C Drugs via Medicaid

Editor's pick
New York Times
26 August 2015
Hepatitis C treatment

Hepatitis C treatment: Back to the warehouse

Editor's pick
Clinical Liver Disease
26 August 2015
People who inject drugs

While Washington Tackles Opioid Abuse Epidemic, Hepatitis C Treatment Remains Unaffordable

Editor's pick
National Journal
19 August 2015
New & experimental hepatitis C treatment

Hepatitis C patients in England denied lifesaving liver drug

Editor's pick
The Observer
18 August 2015
Harm reduction

How the Heroin Crisis Ushered in a Hepatitis C Epidemic

Editor's pick
Boston magazine
12 August 2015
Hepatitis C treatment

Improving access to, and completion of, hepatitis C treatment

Editor's pick
Public Health England
4 August 2015